Loading...

Channel Therapeutics Corporation

PTHSNYSE
Healthcare
Biotechnology
$25.30
$8.84(53.64%)

Channel Therapeutics Corporation (PTHS) AI-Powered Stock Analysis

See how Channel Therapeutics Corporation scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

empty-state-iconAnalysis data is not available for PTHSAnalysis details for PTHS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Frequently Asked Questions

;